Imipenem/cilastatin/relebactam
id:
imipenem-cilastatin-relebactam-306-14291974
title:
Imipenem/cilastatin/relebactam
text:
Imipenem/cilastatin/relebactam, sold under the brand name Recarbrio, is a fixed-dose combination medication used as an antibiotic. In 2019, it was approved for use in the United States for the treatment of complicated urinary tract and complicated intra-abdominal infections. It is administered via intravenous injection. The most common adverse reactions include nausea, diarrhea, headache, fever and increased liver enzymes. The most common adverse reactions observed in people treated for hospital
brand slug:
wiki
category slug:
encyclopedia
description:
Combination drug
original url:
https://en.wikipedia.org/wiki/Imipenem/cilastatin/relebactam
date created:
date modified:
2024-01-09T09:47:46Z
main entity:
{"identifier":"Q65648491","url":"https://www.wikidata.org/entity/Q65648491"}
image:
fields total:
13
integrity:
14